![David B. Rosen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David B. Rosen
Vorstandsvorsitzender bei Dash Pharmaceuticals LLC
Profil
David B.
Rosen is the founder of Dash Pharmaceuticals LLC.
Prior to founding Dash Pharmaceuticals LLC, he worked as Senior Vice President of Business Development at Actylis Corp.
and as Senior Vice President at Rising Pharmaceuticals, Inc. He completed his undergraduate degree at Queens' College Cambridge.
Aktive Positionen von David B. Rosen
Unternehmen | Position | Beginn |
---|---|---|
Dash Pharmaceuticals LLC
![]() Dash Pharmaceuticals LLC Medical DistributorsDistribution Services Part of NATCO Pharma Ltd., Dash Pharmaceuticals LLC is a front-end pharmaceutical sales, marketing and distribution company. The company is based in Upper Saddle River, NJ. The company was founded by Julie Trendowicz, Nick DiMaio, David B. Rosen. David B. Rosen has been the CEO since incorporation. Dash Pharmaceuticals was acquired by NATCO Pharma, Inc. on January 01, 2022 for $18 million. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von David B. Rosen
Unternehmen | Position | Ende |
---|---|---|
Rising Pharmaceuticals, Inc.
![]() Rising Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Rising Pharmaceuticals, Inc. engaged in selling niche pharmaceutical products. It offers Amiloride Hydrochloride tablets, Anastrozole tablets, Benazepril, Bethanechol, Carisoprodol, Cetirizine Hydrochloride, Cevimeline Hydrochloride, Chloroquine Phophate, and Ciprofloxacin Opthalmic Solutions. The company is headquartered in Saddle Brook, NJ. | Corporate Officer/Principal | 31.12.2013 |
ACETO CORPORATION | Corporate Officer/Principal | - |
Ausbildung von David B. Rosen
Queens' College Cambridge | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Actylis Corp.
![]() Actylis Corp. Pharmaceuticals: GenericHealth Technology Actylis Corp. engages in the development, marketing, sale, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment supplies active pharmaceutical ingredients and pharmaceutical intermediates. The Performance Chemicals segment comprises of specialty chemicals and agricultural protection products. The company was founded in 1947 and is headquartered in Port Washington, NY. | Health Technology |
Rising Pharmaceuticals, Inc.
![]() Rising Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Rising Pharmaceuticals, Inc. engaged in selling niche pharmaceutical products. It offers Amiloride Hydrochloride tablets, Anastrozole tablets, Benazepril, Bethanechol, Carisoprodol, Cetirizine Hydrochloride, Cevimeline Hydrochloride, Chloroquine Phophate, and Ciprofloxacin Opthalmic Solutions. The company is headquartered in Saddle Brook, NJ. | Retail Trade |
Dash Pharmaceuticals LLC
![]() Dash Pharmaceuticals LLC Medical DistributorsDistribution Services Part of NATCO Pharma Ltd., Dash Pharmaceuticals LLC is a front-end pharmaceutical sales, marketing and distribution company. The company is based in Upper Saddle River, NJ. The company was founded by Julie Trendowicz, Nick DiMaio, David B. Rosen. David B. Rosen has been the CEO since incorporation. Dash Pharmaceuticals was acquired by NATCO Pharma, Inc. on January 01, 2022 for $18 million. | Distribution Services |